Oncology Fellows
September 2018
June 2018
March 2018
December 2017
September 2017
June 2017
March 2017
December 2016
September 2016
Volume: 8
Issue: 3
June 2016
March 2016
Volume: 8
Issue: 1
December 2015
Volume: 7
Issue: 4
September 2015
Volume: 7
Issue: 3
June 2015
Volume: 7
Issue: 2
March 2015
Volume: 7
Issue: 1
December 2014
Volume: 6
Issue: 4
September 2014
Volume: 6
Issue: 3
June 2014
Volume: 6
Issue: 2
March 2014
Volume: 6
Issue: 1
December 2013
Volume: 5
Issue: 4
October 2013
Volume: 5
Issue: 3
August 2013
Volume: 5
Issue: 2
May 2013
Volume: 5
Issue: 1
December 2012
Volume: 4
Issue: 4
September 2012
Volume: 4
Issue: 3
June 2012
Volume: 4
Issue: 2
April 2012
Volume: 4
Issue: 1
December 2011
Volume: 3
Issue: 4
October 2011
Volume: 3
Issue: 3
July 2011
Volume: 3
Issue: 2
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
3
Dr Braunstein on the FDA Approval of Subcutaneous Daratumumab With VRd For Newly Diagnosed Multiple Myeloma
4
Ixazomib-Containing Combinations Signal Potential for More PI-Based Regimens in R/R Multiple Myeloma
5